STOCK TITAN

DXP Enterprises CEO gets stock grant, makes gift

DXP Enterprises Inc. Chairman and CEO David R. Little reported mixed stock transactions involving DXP Common Stock.

(Very High)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

DXP Enterprises Inc. Chairman and CEO David R. Little reported mixed stock transactions involving DXP Common Stock. He received a grant of 11,797 shares at $138.47 per share, which will vest in equal amounts over three years from the March 2, 2026 grant date. He also made a bona fide gift of 2,385 shares at $140.47 per share. After these transactions, he directly holds 1,240,262 DXP shares.

Positive

  • None.

Negative

  • None.
Insider LITTLE DAVID R
Role Chairman & CEO
Type Security Shares Price Value
Grant/Award DXP Common Stock 11,797 $138.47 $1.63M
Gift DXP Common Stock 2,385 $140.47 $335K
Holdings After Transaction: DXP Common Stock — 1,240,262 shares (Direct)
Footnotes (1)
  1. F1. The terms of the grant provide for vesting in equal amounts over three years on the anniversary date of the grant. Grant date March 2, 2026 - 11,797 shares.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did DXPE Chairman & CEO David R. Little report?

David R. Little reported a stock grant and a gift of DXP Enterprises shares. He acquired 11,797 shares through a grant and disposed of 2,385 shares as a bona fide gift, reflecting mixed but relatively small changes to his overall direct holdings.

How many DXP Enterprises (DXPE) shares were granted to the CEO and at what price?

The CEO received a grant of 11,797 DXP Common Stock shares valued at $138.47 per share. This award increases his direct ownership and is structured to vest over time, aligning part of his compensation with the company’s long-term stock performance.

What are the vesting terms for David R. Little’s new DXPE stock grant?

The 11,797-share grant to David R. Little vests in equal amounts over three years on each anniversary of the March 2, 2026 grant date. This multi-year vesting schedule is designed to retain leadership and link compensation to longer-term shareholder outcomes.

Did the DXP Enterprises CEO sell any shares in this Form 4 filing?

The filing does not show open-market sales; it reports a bona fide gift. David R. Little transferred 2,385 DXP Common Stock shares as a gift, categorized as a disposition, while separately receiving a time-vested equity grant increasing his overall awarded shares.

What is David R. Little’s direct DXP Enterprises share ownership after these transactions?

Following the reported grant and gift transactions, David R. Little directly owns 1,240,262 DXP Common Stock shares. This figure reflects his updated direct holdings after both the acquisition from the equity award and the disposition related to the bona fide stock gift.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
LITTLE DAVID R

(Last) (First) (Middle)
5301 HOLLISTER ST

(Street)
HOUSTON TX 77040

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DXP ENTERPRISES INC [ DXPE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
X Officer (give title below) Other (specify below)
Chairman & CEO
3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
DXP Common Stock 03/03/2026 A 11,797(1) A $138.47 1,242,647 D
DXP Common Stock 03/03/2026 G 2,385 D $140.47 1,240,262 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The terms of the grant provide for vesting in equal amounts over three years on the anniversary date of the grant. Grant date March 2, 2026 - 11,797 shares.
Remarks:
/s/ David R. Little 03/04/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Keep reading